Brief: Arcutis Provides Update on sNDA for Roflumilast Cream 0.15% for Atopic Dermatitis

Arcutis Biotherapeutics

09/07/2024 13:22

July 9 (Reuters) - Arcutis Biotherapeutics Inc  ARQT.O :
    * ARCUTIS PROVIDES UPDATE ON SNDA FOR ROFLUMILAST CREAM
0.15% FOR
ATOPIC DERMATITIS
    * ARCUTIS BIOTHERAPEUTICS: HAS BEEN IN COMMUNICATION WITH
U.S FDA
. REGARDING ITS SUPPLEMENTAL NEW DRUG APPLICATION (SNDA) FOR
ROFLUMILAST CREAM 0.15%
    * ARCUTIS BIOTHERAPEUTICS: FDA INDICATED THAT THEY ARE
WORKING TO
FINALIZE ACTION LETTER & HAVE NOT INDICATED THEY WOULD EXTEND
PDUFA GOAL DATE OF JUL 7

Source text for Eikon:  ID:nGNX9PyYnH 
Further company coverage:  ARQT.O 

 ((Reuters.Briefs@thomsonreuters.com;))